MAR 28, 2016 07:08 AM PDT

Doctors Model Metastasis in 3D with Mini-Organs on a Chip

WRITTEN BY: Xuan Pham
Precision medicine is an emerging field where clinicians tailor treatment plans for each individual based on their genetic history, lifestyle, and environment. Taking this approach one step further, researchers have developed mini-model of the human body and cancer that can predict the route of metastasis and which drugs may prevent this from occurring.
 
The system, known as “metastasis-on-a-chip”, is the first laboratory invention to model cancer spread in 3D. It was developed by researchers at the Wake Forest Baptist Medical Center's Institute for Regenerative Medicine, who published their findings in the latest issue of Biotechnology and Bioengineering.
 
Micro-tissue engineering and cancer metastasis

"We believe the metastasis-on-a-chip system has potential for making meaningful advances in cancer investigation and drug discovery," said Aleksander Skardal, lead author of the study. As the first proof-of-principle study, the team focused on metastasis from the colon to the liver, a common route seen in invasive colorectal cancer.
 
To model cancer migration in 3D, researchers first needed to mimic organs and blood flow, as in a living system. They took human cells from the intestines and liver and encapsulated these in a gel-like substance to create two distinct mini organoids held in independent chambers. The device holding the organoids had etched micro-channels through which researchers simulated blood flow. These channels also provided a means for testing drug treatments.
 
By tagging the cancerous colorectal cells with a fluorescent protein, the researchers could track the cells’ migration in real time. With highly invasive colorectal cancer cells, researchers observed tumor growth in the colon organoid and subsequent metastasis to the liver organoid via the circulatory system. Metastasis was not observed in a non-invasive colorectal cell line.
 
Metastasis can be inhibited by some anti-cancer drugs. To test this intervention in the chip system, the researchers introduced Marimastat and 5-fluorouracil in two separate trials. They found Marimastat led to confinement of the tumor in the primary colon organoid, while 5-fluorouracil reduced the cancer cells’ metabolic activity.
 
So far, the team is impressed with how the device mimics responses in patients. They plan to test more compounds to assess whether the same human effects can be gleaned from the chip system. "If this link can be validated and expanded, we believe the system can be used to screen drug candidates for patients as a tool in personalized medicine. If we can create the same model systems, only with tumor cells from an actual patient, then we believe we can use this platform to determine the best therapy for any individual patient," said Skardal.
 
While this 3D cancer modeling is a huge advancement over 2D systems in petri dishes, much more work has to be done before “metastasis-on-a-chip” can realistically mimic a human system. For example, many organs and multiple pathways are often involved in real metastatic events. Thus the model has to be able to incorporate these real complexities to provide meaningful calculations about cancer response and migration. The team plans to address this by adding more organoids, such as the lung and bone marrow. Additionally, they also plan to add a layer of endothelial cell barrier in channels of the device, to mimic a more realistic circulatory system.
 
Researchers hope their reductionist approach to studying metastasis has the potential to advance cancer investigation and drug discovery, providing more tailored and precise treatments for cancer patients. 
 
 
Additional source: Wake Forest press release
About the Author
  • I am a human geneticist, passionate about telling stories to make science more engaging and approachable. Find more of my writing at the Hopkins BioMedical Odyssey blog and at TheGeneTwist.com.
You May Also Like
OCT 19, 2019
Cancer
OCT 19, 2019
Why some cancers receive more research funding
In a new study from Northwestern Medicine, researchers analyzed which types of cancer receive the most and least amounts of research funding. Their results...
OCT 19, 2019
Health & Medicine
OCT 19, 2019
A Skin Patch Might be the Most Effective Melanoma Treatment
Researchers from the Massachusetts Institute of Technology (MIT) have developed a fast-acting skin patch that effectively delivers cancer-fighting medicati...
OCT 19, 2019
Cell & Molecular Biology
OCT 19, 2019
Dysfunctional Mitochondria Cause Telomere Damage
"I like to call it 'the Chernobyl effect' -- you've turned the reactor on and now you can't turn it off," said senior author Bennett Van Houten, Ph.D....
OCT 19, 2019
Cancer
OCT 19, 2019
Treating glioblastomas through the bloodstream
New research published in Nature Communications details a novel immunotherapy that is capable of treating brain cancer via the bloodstream. Although only p...
OCT 19, 2019
Cell & Molecular Biology
OCT 19, 2019
New Type of CAR T-Cell Therapy Headed for Clinical Trials
Scientists have been trying to use the immune system in cancer patients' bodies to fight cancer....
OCT 19, 2019
Cancer
OCT 19, 2019
Not worth the risk: e-cigs and lung inflammation
E-cigarette use is on the rise and according to new research published in the journal Cancer Prevention Research, even short-term usage of e-cigs can be a ...
Loading Comments...